EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Changes in intestinal microbiota and abnormal amino acid metabolism lead to neurotransmitter disorders in patients with liver cirrhosis

Xiaohu Gao, Keju Zhou, Shaoshan Li iD

Acta Microbiologica et Immunologica Hungarica · 2025

DOI: 10.1556/030.2025.02693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2025. Verfasst von Xiaohu Gao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang City, 453000, Henan Province, China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Gastrointestinal Microbiome, Neurotransmitter Agents, Amino Acids. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 16S rRNA sequencing technology was used to investigate changes in the abundance of intestinal microbiota, metabolites of blood and fecal samples were analyzed and their relationships with neurotransmitters were evaluated in patients with liver cirrhosis after hepatitis B infection. The liver function phenotypes correlated with Phylum Proteobacteria, Class Clostridia and Gamma Proteobacteria, Family Enterobacteriaceae, Ruminococcaceae, Streptococcaceae, Lachnospiraceae and Lactobacillaceae, Genus Faecalibacterium, Streptococcus, species Escherichia coli , etc. Genus Streptococcus has a good diagnostic value for patients with liver cirrhosis in the COM (Compensated liver disease) group, with an AUC of 0.81 (95% CI: 0.70–0.92), while Genus Streptococcus, Veillonella, Faecalibacterium, Blautia, and Bacteroides have a better diagnostic value for patients with liver cirrhosis in the DECOM (Decompensated liver disease) group (including DECOM1 and DECOM2), with the combined AUC reaching 0.93 (95% CI: 0.88–0.98). The level of ammonia in the DECOM2 group was significantly higher than that of the COM group ( P < 0.01). Patients with post-hepatitis B cirrhosis have intestinal flora disorder, which leads to abnormal amino acid metabolism and further leads to neurotransmitter disorder in patients with cirrhosis and accelerates the disease progression. Probiotics can reduce the serum ammonia level in patients with cirrhosis and may prevent the occurrence of hepatic encephalopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisGastrointestinal MicrobiomeNeurotransmitter AgentsAmino AcidsBacteriaHumansMaleMiddle AgedFemaleAdultFecesAgedRNA, Ribosomal, 16SHepatitis B

Stichwörter der Autor:innen

16s rRNA sequencinggut microbiotahepatitis Bliver cirrhosisneurotransmitter disorder

Substanzen

Neurotransmitter AgentsAmino AcidsRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of General Surgery, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang City, 453000, Henan Province, China.

ORCID-Profile: Shaoshan Li

Zitieren

APA

Gao, X., Zhou, K., & Li, S. (2025). Changes in intestinal microbiota and abnormal amino acid metabolism lead to neurotransmitter disorders in patients with liver cirrhosis. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2025.02693

Vancouver

Gao X, Zhou K, Li S. Changes in intestinal microbiota and abnormal amino acid metabolism lead to neurotransmitter disorders in patients with liver cirrhosis. Acta Microbiologica et Immunologica Hungarica. 2025. doi:10.1556/030.2025.02693

BibTeX
@article{Gao2025,
  author = {Gao, Xiaohu and Zhou, Keju and Li, Shaoshan},
  title = {Changes in intestinal microbiota and abnormal amino acid metabolism lead to neurotransmitter disorders in patients with liver cirrhosis},
  journal = {Acta Microbiologica et Immunologica Hungarica},
  year = {2025},
  doi = {10.1556/030.2025.02693}
}
Kostenlos starten →